Boryung Corporation

Based in Seoul, South Korea, Boryung Corporation is a pharmaceutical company dedicated to the creation, manufacturing, and distribution of a diverse range of medical products. Their comprehensive offerings include treatments for cardiovascular ailments, oncology drugs, gastrointestinal therapies, and crucial active pharmaceutical ingredients (APIs). Established in 1957, the firm boasts a considerable global footprint, exporting its pharmaceuticals to approximately 50 countries across six continents. Notable international markets include Japan, China, the vast regions of Southeast Asia and the Middle East, in addition to Europe, South America, and Africa. The company officially transitioned its name from Boryung Pharmaceutical Co., Ltd. to its current designation, Boryung Corporation, in March 2022.

CEO: Jung-Gyun Kim - https://www.boryung.co.kr